| # | Drug | Count |
|---|---|---|
| 0 | METHOTREXATE SODIUM | 586 |
| 1 | METHOTREXATE | 449 |
| 2 | CYTARABINE | 78 |
| 3 | METOPROLOL TARTRATE | 69 |
| 4 | DEXAMETHASONE | 68 |
| 5 | DEXAMETHASONE 1.5 MG | 68 |
| 6 | FUROSEMIDE | 67 |
| 7 | METOPROLOL | 66 |
| 8 | LORAZEPAM | 61 |
| 9 | METFORMIN | 61 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ENSITRELVIR | 3 | 0.1667 |
| 1 | SALICYCLIC ACID | 1 | 0.1000 |
| 2 | FLUMAZENIL | 29 | 0.0327 |
| 3 | GLUCARPIDASE | 9 | 0.0248 |
| 4 | GUAIFENESIN AND CODEINE PHOSPHATE | 2 | 0.0150 |
| 5 | NALBUPHINE HYDROCHLORIDE | 3 | 0.0132 |
| 6 | PRIMAQUINE PHOSPHATE | 1 | 0.0115 |
| 7 | NITAZOXANIDE | 4 | 0.0115 |
| 8 | PIOGLITAZONE AND GLIMEPIRIDE | 1 | 0.0108 |
| 9 | GADOPICLENOL | 2 | 0.0072 |
| # | Drug class | Count |
|---|---|---|
| 0 | Folate Analog Metabolic Inhibitor [EPC] | 450 |
| 1 | Corticosteroid [EPC] | 164 |
| 2 | Benzodiazepine [EPC] | 134 |
| 3 | Nonsteroidal Anti-inflammatory Drug [EPC] | 118 |
| 4 | Alkylating Drug [EPC] | 113 |
| 5 | Loop Diuretic [EPC] | 105 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 85 |
| 7 | Proton Pump Inhibitor [EPC] | 78 |
| 8 | Atypical Antipsychotic [EPC] | 75 |
| 9 | Platinum-based Drug [EPC] | 68 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Benzodiazepine Antagonist [EPC] | 29 | 0.0327 |
| 1 | Carboxypeptidase [EPC] | 9 | 0.0248 |
| 2 | Mucocutaneous Epithelial Cell Growth Factor [EPC] | 1 | 0.0026 |
| 3 | Paramagnetic Contrast Agent [EPC] | 11 | 0.0024 |
| 4 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 18 | 0.0021 |
| 5 | Asparagine-specific Enzyme [EPC] | 22 | 0.0016 |
| 6 | Monobactam Antibacterial [EPC] | 3 | 0.0011 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 450 | 0.0010 |
| 8 | Anti-anginal [EPC] | 10 | 0.0009 |
| 9 | Tetracycline-class Antibacterial [EPC] | 7 | 0.0009 |